The report – which can be viewed here – highlights the following new medicines: 1) Novo Nordisk's Awiqli (LAI 287; insulin ... fixed-dose combination of an amylin analogue and GLP-1 agonist ...

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

Ascletis Pharma’s rapid-fire expansion into obesity drug development has passed another milestone. | Ascletis Pharma’s ...

Allurion Technologies (ALUR) announced its intention to initiate a clinical study on the combination of the Allurion Balloon with GLP-1 ...

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

Novo Nordisk’s bid to provide a once-weekly basal insulin ... the FDA may approve insulin icodec for use in type 2 diabetes only, which is a much larger market than type 1, but the manufacturing ...

Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is an important and evolving form of insulin delivery, which is mainly used for people with type 1 diabetes.

Ozempic is synonymous with weight loss for many people, even as they can turn to drugs with other brand names that have been tailored to treat obesity. The blockbuster Type 2 diabetes medication ...

These are some of the trends in weight management retailers and manufacturers are keeping an eye on in the new year to help ...

BIRMINGHAM, Ala. (WBRC) - Glucagon-like peptide-1 (GLP-1) is a well-known medication used by physicians to treat Type 2 diabetes. GLP-1 has also become popular when used as a weight loss drug. But, ...